DP
NVO

DDD Partners’s Novo Nordisk NVO Stock Holding History

DDD Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,574
Closed -$676K – 83
2022
Q3 		$676K Sell
13,574
-373,070
-96% -$20M 0.12% 47
2022
Q2 		$21.5M Buy
386,644
+3,864
+1% +$214K 3.74% 9
2022
Q1 		$21.3M Buy
382,780
+156,190
+69% +$8.02M 2.91% 12
2021
Q4 		$12.7M Buy
+226,590
New +$12.3M 1.74% 24

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

DDD Partners's NVO Position: Q4 2022 in Review

DDD Partners sold out of Novo Nordisk (NVO) in Q4 2022, closing a stake of 13,574 shares — an estimated $676K sold.

DDD Partners first reported a position in NVO in Q4 2021 and held it in 4 quarters. The position peaked at $21.5M in Q2 2022. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • DDD Partners reported no remaining Novo Nordisk position as of Q4 2022 after selling out during the quarter.
  • DDD Partners sold 13,574 Novo Nordisk shares in Q4 2022, an estimated $676K.
  • DDD Partners first reported a position in Novo Nordisk in Q4 2021 and held it in 4 quarters.
  • DDD Partners's Novo Nordisk position peaked at $21.5M in Q2 2022.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on DDD Partners's 13F filing for Q4 2022, filed 14 Feb 2023.